Global Point of Care Testing for Infectious Disease Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Point of Care Testing for Infectious Disease Revenue
• 1.4 Market
  • 1.4.1 Global Point of Care Testing for Infectious Disease Market Size Growth Rate : 2020 VS 2026
  • 1.4.2 Immunological Test
  • 1.4.3 Pathogen Nucleic Acid Test
• 1.5 Market by Application
  • 1.5.1 Global Point of Care Testing for Infectious Disease Market Share 7: 2020 VS 2026
  • 1.5.2 Hospital
  • 1.5.3 Clinics
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Point of Care Testing for Infectious Disease Market Perspective (2015-2026)
• 2.2 Global Point of Care Testing for Infectious Disease Growth Trends by Regions
  • 2.2.1 Point of Care Testing for Infectious Disease Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Point of Care Testing for Infectious Disease Historic Market Share by Regions (2015-2020)
  • 2.2.3 Point of Care Testing for Infectious Disease Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Point of Care Testing for Infectious Disease Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Point of Care Testing for Infectious Disease Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Point of Care Testing for Infectious Disease Players by Market Size
  • 3.1.1 Global Top Point of Care Testing for Infectious Disease Players by Revenue (2015-2020)
  • 3.1.2 Global Point of Care Testing for Infectious Disease Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Point of Care Testing for Infectious Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Point of Care Testing for Infectious Disease Market Concentration Ratio
  • 3.2.1 Global Point of Care Testing for Infectious Disease Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Point of Care Testing for Infectious Disease Revenue in 2019
• 3.3 Point of Care Testing for Infectious Disease Key Players Head office and Area Served
• 3.4 Key Players Point of Care Testing for Infectious Disease Product Solution and Service
• 3.5 Date of Enter into Point of Care Testing for Infectious Disease Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size (2015-2026)

• 4.1 Global Point of Care Testing for Infectious Disease Historic Market Size (2015-2020)
• 4.2 Global Point of Care Testing for Infectious Disease Forecasted Market Size (2021-2026)

5 Market Size 7 (2015-2026)

• 5.1 Global Point of Care Testing for Infectious Disease Market Size 7 (2015-2020)
• 5.2 Global Point of Care Testing for Infectious Disease Forecasted Market Size 7 (2021-2026)

6 North America

• 6.1 North America Point of Care Testing for Infectious Disease Market Size (2015-2020)
• 6.2 Point of Care Testing for Infectious Disease Key Players in North America (2019-2020)
• 6.3 North America Point of Care Testing for Infectious Disease Market Size (2015-2020)
• 6.4 North America Point of Care Testing for Infectious Disease Market Size 7 (2015-2020)

7 Europe

• 7.1 Europe Point of Care Testing for Infectious Disease Market Size (2015-2020)
• 7.2 Point of Care Testing for Infectious Disease Key Players in Europe (2019-2020)
• 7.3 Europe Point of Care Testing for Infectious Disease Market Size (2015-2020)
• 7.4 Europe Point of Care Testing for Infectious Disease Market Size 7 (2015-2020)

8 China

• 8.1 China Point of Care Testing for Infectious Disease Market Size (2015-2020)
• 8.2 Point of Care Testing for Infectious Disease Key Players in China (2019-2020)
• 8.3 China Point of Care Testing for Infectious Disease Market Size (2015-2020)
• 8.4 China Point of Care Testing for Infectious Disease Market Size 7 (2015-2020)

9 Japan

• 9.1 Japan Point of Care Testing for Infectious Disease Market Size (2015-2020)
• 9.2 Point of Care Testing for Infectious Disease Key Players in Japan (2019-2020)
• 9.3 Japan Point of Care Testing for Infectious Disease Market Size (2015-2020)
• 9.4 Japan Point of Care Testing for Infectious Disease Market Size 7 (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Point of Care Testing for Infectious Disease Market Size (2015-2020)
• 10.2 Point of Care Testing for Infectious Disease Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Point of Care Testing for Infectious Disease Market Size by Type (2015-2020)
• 10.4 Southeast Asia Point of Care Testing for Infectious Disease Market Size by Application (2015-2020)

11 India

• 11.1 India Point of Care Testing for Infectious Disease Market Size (2015-2020)
• 11.2 Point of Care Testing for Infectious Disease Key Players in India (2019-2020)
• 11.3 India Point of Care Testing for Infectious Disease Market Size by Type (2015-2020)
• 11.4 India Point of Care Testing for Infectious Disease Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Point of Care Testing for Infectious Disease Market Size (2015-2020)
• 12.2 Point of Care Testing for Infectious Disease Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Point of Care Testing for Infectious Disease Market Size by Type (2015-2020)
• 12.4 Central & South America Point of Care Testing for Infectious Disease Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Abbott
  • 13.1.1 Abbott Company Details
  • 13.1.2 Abbott Business Overview
  • 13.1.3 Abbott Point of Care Testing for Infectious Disease Introduction
  • 13.1.4 Abbott Revenue in Point of Care Testing for Infectious Disease Business (2015-2020))
  • 13.1.5 Abbott Recent Development
• 13.2 Roche
  • 13.2.1 Roche Company Details
  • 13.2.2 Roche Business Overview
  • 13.2.3 Roche Point of Care Testing for Infectious Disease Introduction
  • 13.2.4 Roche Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
  • 13.2.5 Roche Recent Development
• 13.3 Siemens
  • 13.3.1 Siemens Company Details
  • 13.3.2 Siemens Business Overview
  • 13.3.3 Siemens Point of Care Testing for Infectious Disease Introduction
  • 13.3.4 Siemens Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
  • 13.3.5 Siemens Recent Development
• 13.4 Danaher
  • 13.4.1 Danaher Company Details
  • 13.4.2 Danaher Business Overview
  • 13.4.3 Danaher Point of Care Testing for Infectious Disease Introduction
  • 13.4.4 Danaher Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
  • 13.4.5 Danaher Recent Development
• 13.5 Becton, Dickinson
  • 13.5.1 Becton, Dickinson Company Details
  • 13.5.2 Becton, Dickinson Business Overview
  • 13.5.3 Becton, Dickinson Point of Care Testing for Infectious Disease Introduction
  • 13.5.4 Becton, Dickinson Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
  • 13.5.5 Becton, Dickinson Recent Development
• 13.6 Johnson & Johnson
  • 13.6.1 Johnson & Johnson Company Details
  • 13.6.2 Johnson & Johnson Business Overview
  • 13.6.3 Johnson & Johnson Point of Care Testing for Infectious Disease Introduction
  • 13.6.4 Johnson & Johnson Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
  • 13.6.5 Johnson & Johnson Recent Development
• 13.7 Instrumentation Laboratory
  • 13.7.1 Instrumentation Laboratory Company Details
  • 13.7.2 Instrumentation Laboratory Business Overview
  • 13.7.3 Instrumentation Laboratory Point of Care Testing for Infectious Disease Introduction
  • 13.7.4 Instrumentation Laboratory Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
  • 13.7.5 Instrumentation Laboratory Recent Development
• 13.8 PTS Diagnostics
  • 13.8.1 PTS Diagnostics Company Details
  • 13.8.2 PTS Diagnostics Business Overview
  • 13.8.3 PTS Diagnostics Point of Care Testing for Infectious Disease Introduction
  • 13.8.4 PTS Diagnostics Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
  • 13.8.5 PTS Diagnostics Recent Development
• 13.9 Quidel
  • 13.9.1 Quidel Company Details
  • 13.9.2 Quidel Business Overview
  • 13.9.3 Quidel Point of Care Testing for Infectious Disease Introduction
  • 13.9.4 Quidel Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
  • 13.9.5 Quidel Recent Development
• 13.10 Sekisui Diagnostics
  • 13.10.1 Sekisui Diagnostics Company Details
  • 13.10.2 Sekisui Diagnostics Business Overview
  • 13.10.3 Sekisui Diagnostics Point of Care Testing for Infectious Disease Introduction
  • 13.10.4 Sekisui Diagnostics Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
  • 13.10.5 Sekisui Diagnostics Recent Development
• 13.11 Nova
  • 10.11.1 Nova Company Details
  • 10.11.2 Nova Business Overview
  • 10.11.3 Nova Point of Care Testing for Infectious Disease Introduction
  • 10.11.4 Nova Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
  • 10.11.5 Nova Recent Development
• 13.12 EKF Diagnostics
  • 10.12.1 EKF Diagnostics Company Details
  • 10.12.2 EKF Diagnostics Business Overview
  • 10.12.3 EKF Diagnostics Point of Care Testing for Infectious Disease Introduction
  • 10.12.4 EKF Diagnostics Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
  • 10.12.5 EKF Diagnostics Recent Development
• 13.13 AccuBioTech
  • 10.13.1 AccuBioTech Company Details
  • 10.13.2 AccuBioTech Business Overview
  • 10.13.3 AccuBioTech Point of Care Testing for Infectious Disease Introduction
  • 10.13.4 AccuBioTech Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
  • 10.13.5 AccuBioTech Recent Development
• 13.14 Trinity Biotech
  • 10.14.1 Trinity Biotech Company Details
  • 10.14.2 Trinity Biotech Business Overview
  • 10.14.3 Trinity Biotech Point of Care Testing for Infectious Disease Introduction
  • 10.14.4 Trinity Biotech Revenue in Point of Care Testing for Infectious Disease Business (2015-2020)
  • 10.14.5 Trinity Biotech Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer